Autonomix Medical opened lower at $1.44, compared with its previous close of $1.48. In the last trading session, the stock traded between $1.31 and $1.44. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 3 years ago in Autonomix Medical is now worth
$ 1.34
Resulting in a loss of
$ 98.66 (98.66%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 1 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
$-0.13 (-8.51%)
Day High
$1.44
Day Low
$1.31
Day Open
$1.44
Prev Close
$1.48
Volume
4,80,468
1W Return
-16.16%
1M Return
-56.85%
3M Return
-85.36%
6M Return
303.70%
1Y Return
59.50%
Fundamentals
Market Cap ($ Mn)
3
PE Ratio
-
PB Ratio
0.91
PEG Ratio
-
ROE
-169.03%
ROCE
-157.10%
EPS (TTM)
-
Investment Returns
1 Week
-16.16%
1 Month
-56.85%
3 Months
-85.36%
6 Months
303.70%
9 Months
250.23%
Financials
Quarterly
All values in $ Mn
0.0
Dec 24
0.0
Mar 25
0.0
Jun 25
0.0
Sep 25
0.0
Dec 25
0.0
Jun 26
Updates
12Nov
Autonomix Medical showcases renal denervation sensing tech at TCT 2026
Presented microchip-enabled sensing platform at TCT 2026 conference. Targeting renal denervation applications to improve hypertension treatment. Aims for commercial offering by end of 2028 pending regulatory approvals. Cites CDC data showing 48.1% of US adults have high blood pressure.
Today
11Nov
Autonomix Medical granted US patent for catheter-based sensing tech
Autonomix Medical Inc received US Patent 12,793,841 for physiological signal devices. Patent covers circuitry for capturing and processing signals near the biological source. Technology supports high-resolution sensing and real-time physiological monitoring. Patent strengthens IP portfolio for proprietary catheter-based sensing technology.
2 days ago
2Oct
Autonomix Medical secures Canadian patent for transvascular platform
Canadian Intellectual Property Office issued Patent No. 3,183,802 to Autonomix Medical. Patent covers transvascular catheter systems for monitoring and treating tissues within lumen walls. Global portfolio now stands at 112 issued or pending patent applications across key jurisdictions.
